From the Greek words arthro, which means “joint” and itis, referring to “inflammation,” arthritis is the number one cause of disability troubling people over the age of 65.

It has several forms, each one with a different cause: osteoarthritis, rheumatoid arthritis, septic arthritis, gout and pseudogout, juvenile arthritis, Still’s disease, and ankylosing spondylitis. Lyprinol, the anti-inflammatory supplement manufactured from the New Zealand green-lipped mussel extract, has been found effective and safe in relieving the most prevalent forms of this condition.

Osteoarthritis, the most common form, is either caused by an infection or an injury to the joint, or is simply caused by aging. It generally affects the larger joints which bear the body’s weight, such as the knees and the hips. In some cases, the end joints of the fingers may be affected.

Numerous clinical trials have demonstrated that Lyprinol may help relieve the pain associated with osteoarthritis, with no gastrointestinal side effects commonly associated with the usual osteoarthritis medications, such as non-steroidal anti-inflammatory drugs (NSAIDs).

Similarly, Lyprinol effectively reduces the swelling associated with rheumatoid arthritis. This type of arthritis is an autoimmune disease in which the body “attacks” itself. It is characterized by extreme pain and can eventually destroy the joints, resulting in loss of mobility.

Rheumatoid arthritis has been found to affect mostly females and generally affects the smaller joints, such those in the toes, fingers, and wrists. To combat this debilitating condition, Lyprinol blocks a certain biochemical pathway which is responsible for the production of inflammatory compounds.

Compared to other marine oil products, Lyprinol has a more intricate lipid structure. It contains substances such as marine sterols and omega-3 fatty acids, known to be potent anti-inflammatory compounds.